Expanding the Spectrum of HER2 Positivity for Breast Cancer Care: Implications of HER2-Low Status

Get up to date on best practices for assessing HER2 status and treating patients with HER2-low breast cancer with downloadable slides from a satellite symposium at SABCS 2022 an on-demand webcast and an expert commentary.

Share

Program Content

Activities

BC: Implications of HER2-Low
Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2022

Expires: December 07, 2023

Precision Care:  HER2-low ABC
ExpressPoints
Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2022

Expires: December 15, 2023

Activities

FAQs: T-DXd in HER2-Low ABC
Frequently Asked Questions: Expanding the Spectrum of HER2 Positivity in Advanced Breast Cancer With T-DXd
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 13, 2023

Expires: February 12, 2024

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca Pharmaceuticals

Daiichi Sankyo, Inc.